{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T20:00:44Z","timestamp":1778788844703,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.clgc.2018.09.012","type":"journal-article","created":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T05:03:31Z","timestamp":1537592611000},"page":"e80-e91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Impact of PI3K-AKT-mTOR Signaling Pathway Up-regulation on Prognosis of Penile Squamous-Cell Carcinoma: Results From a Tissue Microarray Study and Review of the Literature"],"prefix":"10.1016","volume":"17","author":[{"given":"Mounsif","family":"Azizi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominic H.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Verduzco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles C.","family":"Peyton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Chipollini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhigang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Braydon J.","family":"Schaible","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Min","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A.","family":"Johnstone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Giuliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasreman","family":"Dhillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe E.","family":"Spiess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2018.09.012_bib1","first-page":"7","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clgc.2018.09.012_bib2","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/j.urology.2010.04.008","article-title":"Prognostic factors in penile cancer","volume":"76","author":"Ficarra","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.clgc.2018.09.012_bib3","doi-asserted-by":"crossref","first-page":"594","DOI":"10.6004\/jnccn.2013.0075","article-title":"Penile cancer: Clinical Practice Guidelines in Oncology","volume":"11","author":"Clark","year":"2013","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.clgc.2018.09.012_bib4","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.eururo.2014.10.017","article-title":"EAU guidelines on penile cancer: 2014 update","volume":"67","author":"Hakenberg","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2018.09.012_bib5","doi-asserted-by":"crossref","unstructured":"Chipollini J, Chaing S, Azizi M, et\u00a0al. Advances in understanding of penile carcinogenesis: the search for actionable targets. Int J Mol Sci 18, 2017.","DOI":"10.3390\/ijms18081777"},{"key":"10.1016\/j.clgc.2018.09.012_bib6","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1158\/1535-7163.MCT-07-2408","article-title":"Mammalian target of rapamycin inhibition as a therapeutic strategy in the management of urologic malignancies","volume":"7","author":"Garcia","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.clgc.2018.09.012_bib7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.currproblcancer.2015.03.005","article-title":"Molecular markers in penile cancer","volume":"39","author":"Rodney","year":"2015","journal-title":"Curr Probl Cancer"},{"key":"10.1016\/j.clgc.2018.09.012_bib8","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fonc.2014.00064","article-title":"Targeting PI3K\/Akt\/mTOR signaling in cancer","volume":"4","author":"Porta","year":"2014","journal-title":"Front Oncol"},{"key":"10.1016\/j.clgc.2018.09.012_bib9","first-page":"2030","article-title":"PIK3CA, HRAS and KRAS gene mutations in human penile cancer","volume":"179","author":"Andersson","year":"2008","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.clgc.2018.09.012_bib10","first-page":"36","article-title":"The role of mTOR signaling pathway in premalignant and malignant cervical lesions","volume":"36","author":"Andrikopoulou","year":"2015","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.clgc.2018.09.012_bib11","first-page":"2288","article-title":"mTOR signaling pathway in penile squamous cell carcinoma: pmTOR and peIF4E over expression correlate with aggressive tumor behavior","volume":"190","author":"Ferrandiz-Pulido","year":"2013","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.clgc.2018.09.012_bib12","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/his.12338","article-title":"Immunohistochemical expression of the mammalian target of rapamycin pathway in penile squamous cell carcinomas: a tissue microarray study of 112 cases","volume":"64","author":"Chaux","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/j.clgc.2018.09.012_bib13","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.humpath.2015.01.018","article-title":"Immunohistochemical expression of ARID1A in penile squamous cell carcinomas: a tissue microarray study of 112 cases","volume":"46","author":"Faraj","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1016\/j.clgc.2018.09.012_bib14","doi-asserted-by":"crossref","first-page":"e17517","DOI":"10.1371\/journal.pone.0017517","article-title":"Alternative HER\/PTEN\/Akt pathway activation in HPV positive and negative penile carcinomas","volume":"6","author":"Stankiewicz","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.clgc.2018.09.012_bib15","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clgc.2018.09.012_bib16","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.clgc.2015.12.019","article-title":"Clinical significance of p53 and p16(ink4a) status in a contemporary North American penile carcinoma cohort","volume":"14","author":"Zargar-Shoshtari","year":"2016","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.clgc.2018.09.012_bib17","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/00000478-199009000-00004","article-title":"Detection of human papillomavirus DNA in penile lesions histologically negative for condylomata. Analysis by in situ hybridization and the polymerase chain reaction","volume":"14","author":"Nuovo","year":"1990","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clgc.2018.09.012_bib18","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/jcp.48.9.876","article-title":"A\u00a0\u201cquickscore\u201d method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas","volume":"48","author":"Detre","year":"1995","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.clgc.2018.09.012_bib19","doi-asserted-by":"crossref","first-page":"726","DOI":"10.2105\/AJPH.86.5.726","article-title":"Adjusting for multiple testing when reporting research results: the Bonferroni vs. Holm methods","volume":"86","author":"Aickin","year":"1996","journal-title":"Am J Public Health"},{"key":"10.1016\/j.clgc.2018.09.012_bib20","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1186\/s12885-016-2940-7","article-title":"Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis","volume":"16","author":"Li","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clgc.2018.09.012_bib21","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/jop.12390","article-title":"mTOR pathway protein immunoexpression as a prognostic factor for survival in head and neck cancer patients: a systematic review and meta-analysis","volume":"45","author":"Marques","year":"2016","journal-title":"J\u00a0Oral Pathol Med"},{"key":"10.1016\/j.clgc.2018.09.012_bib22","doi-asserted-by":"crossref","first-page":"29780","DOI":"10.18632\/oncotarget.8957","article-title":"Impact of PI3K\/AKT\/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas","volume":"7","author":"Garcia-Carracedo","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.clgc.2018.09.012_bib23","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1002\/jcb.26118","article-title":"The potential value of the PI3K\/Akt\/mTOR signaling pathway for assessing prognosis in cervical cancer and as a target for therapy","volume":"118","author":"Bahrami","year":"2017","journal-title":"J\u00a0Cell Biochem"},{"key":"10.1016\/j.clgc.2018.09.012_bib24","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.3892\/ol.2016.5157","article-title":"Potential impact of mTOR inhibitors on cervical squamous cell carcinoma: a systematic review","volume":"12","author":"Assad","year":"2016","journal-title":"Oncol Lett"},{"key":"10.1016\/j.clgc.2018.09.012_bib25","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1158\/1078-0432.CCR-11-2824","article-title":"mTOR as a molecular target in HPV-associated oral and cervical squamous carcinomas","volume":"18","author":"Molinolo","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clgc.2018.09.012_bib26","first-page":"449","article-title":"Systematic review of human papillomavirus prevalence in invasive penile cancer","volume":"20","author":"Backes","year":"2009","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.clgc.2018.09.012_bib27","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/ijc.21961","article-title":"Presence of high-risk human papillomavirus DNA in penile carcinoma predicts favorable outcome in survival","volume":"119","author":"Lont","year":"2006","journal-title":"Int J Cancer"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767318301538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767318301538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:32:29Z","timestamp":1761564749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767318301538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S1558767318301538"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2018.09.012","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of PI3K-AKT-mTOR Signaling Pathway Up-regulation on Prognosis of Penile Squamous-Cell Carcinoma: Results From a Tissue Microarray Study and Review of the Literature","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2018.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}